Traditional Chinese medicine composition for treating common neocoronavirus pneumonia and preparation and application thereof

Abstract

The invention discloses a traditional Chinese medicine composition for treating common neocoronavirus pneumonia and preparation and application thereof. The traditional Chinese medicine composition isprepared from, by mass, 5-20 parts of roasted herba ephedrae, 10-30 parts of apricot kernels, 10-30 parts of gypsum, 10-30 parts of rhizoma anemarrhenae, 10-30 parts of rhizoma smilacis glabrae, 10-30 parts of fresh rhizoma phragmitis, 10-30 parts of raw coix seeds, 10-30 parts of wax gourd seeds, 10-30 parts of peach kernels, 10-30 parts of wild buckwheat roots, 10-30 parts of fried radix scutellariae, 10-30 parts of radix platycodonis, 10-30 parts of ginger processed pinellia, 10-30 parts of caulis perllae and 10-30 parts of lignum sappan. The traditional Chinese medicine composition obviously improves respiratory symptoms and shortens isolation time; under the guidance of the theory of traditional Chinese medicine, the traditional Chinese medicine composition selects the medicine components according to the treatment principle of clearing heat and eliminating phlegm, traditional Chinese medicinal materials have no obvious toxic or side effect during treatment, and the traditional Chinese medicine composition can be taken for a long time and is wide in application range.

Description

[0001] (1) Technical field [0002] The invention relates to a traditional Chinese medicine composition of Ma Xing Qian Jin for treating common type of new coronary pneumonia, as well as its preparation and application. [0003] (2) Background technology [0004] Since December 2019, there are only six known coronaviruses that can infect humans, of which only SARS-CoV and MERS-CoV can cause fatal pneumonia together, and the other four are HcoV-229E, HcoV-NL63, HcoV-HKU1, The HcoV-OC43 coronavirus can only cause mild respiratory infections. This new type of coronavirus pneumonia seems to cause symptoms similar to SARS. A recent clinical study from China released by Lancet showed that 1 / 3 of 41 laboratory-confirmed 2019-nCoV infected patients required intensive care and 6 died. Five patients had acute cardiac injury, and the latter study, published at the same time, reported clinical and microbiological data from a family of six, confirming the possibility of human-to-human tran...

AI Technical Summary

Problems solved by technology

The situation of the epidemic is severe, and the route of transmission is unknown at present, and there is no specific treatment drug. In view of the actual combat experience during the SARS epidemic in 2003, it is now necessary to give full play to the unique advantages of traditional Chinese medicine in the process of epidemic prevention and treatment

Images